Artt v. Exelixis US LLC

CourtDistrict Court, N.D. Texas
DecidedMarch 28, 2022
Docket3:20-cv-02528
StatusUnknown

This text of Artt v. Exelixis US LLC (Artt v. Exelixis US LLC) is published on Counsel Stack Legal Research, covering District Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Artt v. Exelixis US LLC, (N.D. Tex. 2022).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION

ANITA ARTT, ) ) Plaintiff, ) ) VS. ) CIVIL ACTION NO. ) EXELIXIS US LLC, ) 3:20-CV-2528-G ) Defendant. ) MEMORANDUM OPINION AND ORDER Before the court is the motion of the defendant Exelixis US LLC (“Exelixis”) for summary judgment (docket entry 19). For the following reasons, the motion is granted. I. BACKGROUND Exelixis, an oncology-focused biotechnology company, “develops and commercializes new medicines for difficult-to-treat cancers.” Defendant’s Brief in Support of its Motion for Summary Judgment (“Motion”) (docket entry 20) at 1.

The plaintiff Anita Artt (“Artt”), formerly employed by Exelixis, alleges that Exelixis wrongfully terminated her employment. See generally Plaintiff’s Original Petition and Request for Disclosure (“Petition”), attached to Defendant’s Notice of Removal (“Notice”) (docket entry 1) as Exhibit C; see also Appendix in Support of Defendant Exelixis US LLC’S Motion for Summary Judgment (“Defendant’s Appendix”) (docket entry 21) at APP. 126.

Renee Schmutte (“Schmutte”), then Exelixis’s National Director, Medical Science Liaisons1 (“MSLs”), and William Berg (“Berg”), Exelixis’s Senior Vice President, Medical Affairs, interviewed Artt for a position at Exelixis.2 Motion at 1-2; Defendant’s Appendix at APP. 001-APP. 002. Artt and Berg were former work colleagues. Motion at 2; Defendant’s Appendix at APP. 012. Artt initially

interviewed with Schmutte by telephone, followed by in-person interviews with Schmutte and Berg. Defendant’s Appendix at APP. 012-APP. 015; see also Motion at 2. At the time of the interviews, Schmutte and Berg were close to or over the age of 50, and Artt was 59 years of age.3 Motion at 2; Petition at 2. Schmutte and Berg

1 A Medical Science Liaison is an Exelixis employee “sent out into the field to educate medical professionals about [Exelixis]’s products.” Plaintiff’s Response to Defendant’s Motion for Summary Judgment (“Response”) (docket entry 25) at 2. 2 Schmutte now serves as Exelixis’s Vice President, U.S. MSLs. Defendant’s Appendix at APP. 001. 3 The court notes that, while Exelixis characterizes Schmutte and Berg as being “both over the age of fifty[,]” see Motion at 2, in the context of summarizing the timeline for Artt being interviewed and hired by Exelixis, Schmutte declares that she was 50 years of age at the time of Artt’s termination, see Defendant’s Appendix at APP. 005. Because Exelixis hired Artt in January of 2016, see Motion at 2, and terminated her employment in June of 2019, see id., the court therefore concludes that Schmutte would have been older than 40 years of age but younger than 50 years of age during the process of interviewing and hiring Artt. Similarly, Exelixis incorrectly asserts that it “hired Artt (then age 60)[,]” see id. at 1, however, Artt was (continued...) - 2 - recommended that Exelixis hire Artt. Defendant’s Appendix at APP. 002; see also Motion at 2 (“Schmutte and Berg . . . collectively consulted and made the decision to

hire [Artt] following that interview.”). In January of 2016, Exelixis hired Artt, then age 59, as a Senior Regional Director, MSLs, and Artt was based in Dallas, Texas.4 Motion at 1-2; Response at 2. Artt came to Exelixis as “an accomplished health care professional[.]” Petition at 2; see also Response at 1-2. Artt, as Exelixis’s Senior Regional Director of the Western

Region, reported directly to Schmutte, and Schmutte reported to Berg. Defendant’s Appendix at APP. 001; Motion at 2. Artt’s job duties “included managing and supervising a team of [eight] MSLs who worked remotely throughout the western half of the United States, including San Diego, San Antonio, Seattle, Phoenix,

Houston, and Denver.” Motion at 2; see also Response at 2. Artt “was responsible to fill those positions and to support and oversee the work of the MSLs under her supervision.” Response at 2. At a medical affairs meeting in the summer of 2016, Artt contends that

Schmutte first discovered that Artt was 60 years of age, and thereafter Schmutte

3(...continued) 59 years of age at the time Exelixis interviewed and hired her. See Petition at 2; see also Response at 2. 4 On January 19, 2016, Artt signed an offer letter from Exelixis. See Defendant’s Appendix at APP. 08 l-APP. 082. - 3 - treated Artt differently due to Artt’s age. Defendant’s Appendix at APP. 021. At this meeting, Artt maintains that Schmutte overheard Artt and Artt’s colleague talking

about vacations, a conversation prompted by a photograph displayed on Artt’s computer of Artt wearing a T-shirt which read “Anita is 60[.]” Id. at APP. 021-APP. 023; Response at 2. Schmutte allegedly responded, “Oh, my gosh, I thought you were in your late 40s.” Defendant’s Appendix at APP. 021; see also Response at 2. Exelixis argues that even if Schmutte made this comment, “it does not lead a

reasonable person to conclude that Schmutte’s remark was meant literally . . . [as] individuals may make polite remarks referencing someone looking ‘good for their age’ or ‘looking younger than they are’ in an attempt to be friendly or even be complimentary. Such comments are rarely construed to be taken literally as evidence

of how old the speaker thought the person to be.” Defendant’s Reply Brief in Support of its Motion for Summary Judgment (“Reply”) (docket entry 27) at 6. Also in the summer of 2016, Artt contends that she began to notice that Schmutte and Berg “would get together in groups in the evenings with younger

workers, including the MSLs, and [Artt] and her counterpart from the east coast, Larry O’Neal, who were the older employees at the meetings, would not be included in these social times.” Response at 2-3. In 2017, for example, Artt complains that she was excluded from “casual meetings[,]” which she defines as “go have drinks together” events. Defendant’s Appendix at APP. 028; see also, e.g., id. at APP.

- 4 - 029-APP. 031. According to Artt, these casual meetings took place after normal business hours (i.e., after “6:00 at night”) – “at the end of the day, dinner or

cocktails.” Id. at APP. 031. Artt maintains that “[t]his conduct on the part of Schmutte and Berg continued throughout [Artt]’s employment with Defendant.” Response at 3. However, Artt admits that neither Schmutte nor Berg ever told Artt that she could not join them for any event after work. See, e.g., Defendant’s Appendix at APP. 025, APP. 031.

Artt generally asserts that Schmutte “seemed to want to ‘clump’ herself with younger workers and ignore the older workers, and this sometimes resulted in promotions being given to younger workers who were not qualified for the promotions.” Response at 3. Artt also complains that Schmutte and Berg shared

information with younger Exelixis employees that Artt was not privy to, such as the “[p]olitical inner-workings at the company.” Defendant’s Appendix at APP. 026; see also id. at APP. 027. Further, Artt contends that during 2018 Exelixis awarded new projects and opportunities to “younger employees” whom she supervised while her

“only role was in supervision of her direct reports who were working on the trials.” Response at 3. In 2016 and 2017, Schmutte awarded Artt “positive performance reviews” on annual performance evaluations. Motion at 3. Subsequently, however, Exelixis contends that “as Artt’s employment continued, Schmutte became increasingly aware

- 5 - of significant problems with Artt’s communication and management styles toward subordinate employees and others.” Id.; see also Defendant’s Appendix at APP. 002.

On September 6, 2018, Schmutte addressed “leadership and communication issues with Artt in a 1:1 meeting” and again during Artt’s 2018 mid-year performance review (“2018 Mid-Year Review”) meeting held on September 18, 2018. Motion at 3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brown v. CSC Logic, Inc.
82 F.3d 651 (Fifth Circuit, 1996)
Russell v. McKinney Hospital Venture
235 F.3d 219 (Fifth Circuit, 2001)
Auguster v. Vermilion Parish School Board
249 F.3d 400 (Fifth Circuit, 2001)
Martin v. Bayland Inc.
181 F. App'x 422 (Fifth Circuit, 2006)
Arismendez v. Nightingale Home Health Care, Inc.
493 F.3d 602 (Fifth Circuit, 2007)
Spears v. Patterson UTI Drilling Co.
337 F. App'x 416 (Fifth Circuit, 2009)
Adickes v. S. H. Kress & Co.
398 U.S. 144 (Supreme Court, 1970)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
John Rexses v. The Goodyear Tire & Rubber Co.
401 F. App'x 866 (Fifth Circuit, 2010)
Marian Fontenot, Etc. v. The Upjohn Company
780 F.2d 1190 (Fifth Circuit, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
Artt v. Exelixis US LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/artt-v-exelixis-us-llc-txnd-2022.